Topics

These highlights do not include all the information needed to use ISOSULFAN BLUE INJECTION 1% safely and effectively. See full prescribing information for ISOSULFAN BLUE INJECTION 1%. ISOSULFAN BLUE injection 1% for subcutaneous use onlyInitial U.S. Appro | Isosulfan Blue [Mylan Institutional LLC] | BioPortfolio

13:39 EST 27th January 2019 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Isosulfan blue injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities.

Isosulfan blue injection 1% is to be administered subcutaneously, one-half (1/2) mL into three (3) interdigital spaces of each extremity per study. A maximum dose of 3 mL (30 mg) isosulfan blue is, therefore, injected.

1% aqueous solution (isosulfan blue)

Isosulfan blue injection 1% is contraindicated in those individuals with known hypersensitivity to triphenylmethane or related compounds.

Life threatening anaphylactic reactions (respiratory distress, shock, angio-edema) have occurred after isosulfan blue injection 1% administration. Reactions are more likely to occur in patients with a history of bronchial asthma, allergies, drug reactions or previous reactions to triphenylmethane dyes. Monitor patients closely for at least 60 minutes after administration of isosulfan blue injection 1%. Trained personnel should be available to administer emergency care including resuscitation.

The admixture of isosulfan blue injection 1% (with local anesthetics (i.e. lidocaine)) in the same syringe results in an immediate precipitation of 4% to 9% drug complex. Use a separate syringe to administer a local anesthetic.

Isosulfan blue injection 1% interferes with measurements of oxygen saturation in peripheral blood by pulse oximetry and can cause falsely low readings. The interference effect is maximal at 30 minutes and minimal generally by 4 hours after administration. Arterial blood gas analysis may be needed to verify decreased arterial partial pressure of oxygen.

Isosulfan blue injection 1% may also cause falsely elevated readings of methemoglobin by arterial blood gas analyzer. Therefore, cooximetry may be needed to verify methemoglobin level.

Hypersensitivity Reactions: Case series report an overall incidence of hypersensitivity reactions in approximately 2% of patients. Life threatening anaphylactic reactions have occurred. Manifestations include respiratory distress, shock, angioedema, urticaria, pruritus. A death has been reported following administration of a similar compound employed to estimate the depth of a severe burn. Reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, drug reactions or previous reactions to triphenylmethane dyes [see Warnings and Precautions (5)].

Laboratory Tests: Isosulfan blue injection 1% interferes with measurements of oxygen saturation by pulse oximetry and of methemoglobin by gas analyzer [see Warnings and Precautions (5)].

Skin: transient or long-term (tattooing) blue coloration.

No drug interactions have been identified with isosulfan blue injection 1%.

It is not known whether this drug is excreted in human milk.

Because many drugs are excreted in human milk, caution should be exercised when isosulfan blue injection 1% is administered to a nursing mother.

Safety and effectiveness of isosulfan blue injection 1% in children have not been established.

Do not exceed indicated recommended dosage as overdosage levels have not been identified for isosulfan blue injection 1%.

The chemical name of isosulfan blue injection 1% is N-[4- [[4-(diethylamino)phenyl] (2,5-disulfophenyl) methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium hydroxide, inner salt, sodium salt. Its structural formula is:

ISOSULFAN BLUE

Isosulfan blue injection 1% is a sterile aqueous solution for subcutaneous administration. Phosphate buffer in sterile, pyrogen free water is added in sufficient quantity to yield a final pH of 6.8 to 7.4. Each mL of solution contains 10 mg isosulfan blue, 6.6 mg sodium monohydrogen phosphate and 2.7 mg potassium dihydrogen phosphate. The solution contains no preservative. Isosulfan blue injection 1% is a contrast agent for the delineation of lymphatic vessels.

Following subcutaneous administration, isosulfan blue injection 1% binds to serum proteins and is picked up by the lymphatic vessels. Thus, the lymphatic vessels are delineated by the blue dye.

Up to 10% of the subcutaneously administered dose of isosulfan blue injection 1% is excreted unchanged in the urine in 24 hours in humans.

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of isosulfan blue injection 1%. Reproduction studies in animals have not been conducted and, therefore, it is unknown if a problem concerning mutagenesis or impairment of fertility in either males or females exists.

Pregnancy Category C. Animal reproduction studies have not been conducted with isosulfan blue injection 1%. It is not known whether isosulfan blue injection 1% can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Isosulfan blue injection 1% should be given to a pregnant woman only if clearly needed.

Isosulfan Blue Injection 1% is supplied as a 5 mL single-dose vial, 1% aqueous solution in a phosphate buffer prepared by appropriate manufacturing to be sterile and pyrogen-free.

NDC 67457-586-05carton containing 6 x 5 mL single-dose vials

Storage: Vials should be stored at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Avoid excessive heat.

Inform patients that urine color may be blue for 24 hours following administration of isosulfan blue injection 1%.

Manufactured for: Mylan Institutional LLC Rockford, IL 61103 U.S.A.

Manufactured by: Mylan Institutional Galway, Ireland

PREMIERProRxis a registered trademark of Premier Healthcare Alliance, L.P., used under license.

0873L101

Revised: 7/2017MI/PP:ISOSIJ:R4

PRINCIPAL DISPLAY PANEL - 50 mg/5 mL

NDC 67457-586-05

Isosulfan Blue Injection 1% 50 mg/5 mL (10 mg/mL)

For Lymphography

For Subcutaneous Use Only

PREMIERPro Rx

Rx only     6 x 5 mL Single-Dose Vials

Sterile. Non-Pyrogenic. Single-Dose Container.Contains no preservatives.Not for Multiple-Use.Discard Unused Portion.

Each mL contains: Isosulfan Blue . . . . . . . . . . . . . . . . . . . . . . . . . 10 mgSodium monohydrogen phosphate. . . . . . . . 6.6 mgPotassium dihydrogen phosphate . . . . . . . . 2.7 mg

Consult Accompanying Prescribing Information Before Administering Drug.

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]

Avoid excessive heat.

Manufactured for: Mylan Institutional LLC Rockford, IL 61103 U.S.A.Made in U.S.A.

Manufactured by:Mylan Institutional Galway, Ireland

PREMIERPro Rx

PREMIERPro Rx is a registeredtrademark of Premier HealthcareAlliance, L.P., used under license.

MI:586:6C:R3

Manufacturer

Mylan Institutional LLC

Active Ingredients

Source

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Isosulfan blue [anazaohealth corporation]

Isosulfan Blue 1%

Isosulfan blue [auromedics pharma llc]

These highlights do not include all the information needed to use ISOSULFAN BLUE INJECTION safely and effectively. See full prescribing information for ISOSULFAN BLUE INJECTION. ISOSULFAN BLUE injecti...

Isosulfan blue [auromedics pharma llc]

These highlights do not include all the information needed to use ISOSULFAN BLUE INJECTION safely and effectively. See full prescribing information for ISOSULFAN BLUE INJECTION. ISOSULFAN BLUE injecti...

Isosulfan blue [mylan institutional llc]

These highlights do not include all the information needed to use ISOSULFAN BLUE INJECTION 1% safely and effectively. See full prescribing information for ISOSULFAN BLUE INJECTION 1%. ISOSULFAN BLUE i...

Lymphazurin [united states surgical corporation]

These highlights do not include all the information needed to use LYMPHAZURIN safely and effectively. See full prescribing information for LYMPHAZURIN. LYMPHAZURIN injection, solution for subcutaneous...

Clinical Trials [279 Associated Clinical Trials listed on BioPortfolio]

Breast Lymph Node Mapping

The purpose of this study is to map the arm lymphatic drainage system in the axilla with blue dye and the breast drainage system with a radioactive material. By identifying the arm lymphat...

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

RATIONALE: Diagnostic procedures, such as visceral lymphatic mapping using isosulfan blue, may help find cancer of the pancreas, colon, stomach, small intestine, or gallbladder and find ou...

Improved Method of Detecting Cancer Metastases

The purpose of this study is to compare the Instillation Technique Using The Modified Intra- Uterine Manipulator Catheter With Methylene Blue, Isosulfan Blue or Indocyanine Green Dyes, Com...

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

The goal of this clinical research study is to compare methylene blue (an oral rinse) to standard therapy to learn if one is better, the same, or worse than the other in controlling mucosi...

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

RATIONALE: Diagnostic procedures, such as lymph node mapping and sentinel lymph node identification, performed before and during surgery, may improve the ability to detect lymph node metas...

PubMed Articles [1109 Associated PubMed Articles listed on BioPortfolio]

Allergy-like reactions to methylene blue following laparoscopic chromopertubation: A systematic review of the literature.

Methylene blue is commonly used as a tracer in sentinel lymph node mapping for many malignant diseases or chromopertubation during gynecologic laparoscopy. In contrast with other blue dyes such as pat...

915  nm all-fiber laser based on novel Nd-doped high alumina and yttria glass @ silica glass hybrid fiber for the pure blue fiber laser.

The fiber laser in the range of 900-1000 nm is essential to generate the blue fiber laser through frequency doubling for the laser display, laser underwater communications, and laser lighting. Yet, t...

Gender, Depression, and Blue-collar Work: A Retrospective Cohort Study of US Aluminum Manufacturers.

Industrial blue-collar workers face multiple work-related stressors, but evidence regarding the burden of mental illness among today's blue-collar men and women remains limited.

Photoelectrochemical degradation of 2,4-dichlorophenoxyacetic acid using electrochemically self-doped Blue TiO nanotube arrays with formic acid as electrolyte.

Blue TiO nanotube arrays (Blue-TNTs) were fabricated via an electrochemical reduction method with formic acid as the electrolyte. The optimum reduction conditions were obtained as bias potential of -1...

Molecular doping of blue phosphorene: a first-principles investigation.

Using first-principles calculations, we show that p-doped blue phosphorene can be obtained by molecular doping with 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane (F-TCNQ) and 1,3,4,5,7,8-hexafl...

Quick Search

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record